Cargando…
Gene therapies development: slow progress and promising prospect
Background: In 1989, the concept of human gene therapies has emerged with the first approved human gene therapy trial of Rosenberg et al. Gene therapies are considered as promising therapies applicable to a broad range of diseases. Objective: The objective of this study was to review the descriptive...
Autores principales: | Hanna, Eve, Rémuzat, Cécile, Auquier, Pascal, Toumi, Mondher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328344/ https://www.ncbi.nlm.nih.gov/pubmed/28265348 http://dx.doi.org/10.1080/20016689.2017.1265293 |
Ejemplares similares
-
Advanced therapy medicinal products: current and future perspectives
por: Hanna, Eve, et al.
Publicado: (2016) -
Risk of discontinuation of Advanced Therapy Medicinal Products clinical trials
por: Hanna, Eve, et al.
Publicado: (2016) -
Value added medicines: what value repurposed medicines might bring to society?
por: Toumi, Mondher, et al.
Publicado: (2016) -
Market access pathways for cell therapies in France
por: Rémuzat, Cécile, et al.
Publicado: (2015) -
New drug regulations in France: what are the impacts on market access? Part 1 – Overview of new drug regulations in France
por: Rémuzat, Cécile, et al.
Publicado: (2013)